Factors Determining Adequacy of Axillary Node Dissection in Breast Cancer Patients-Reference-Cited by-同舟云学术

Factors Determining Adequacy of Axillary Node Dissection in Breast Cancer Patients

Published:2007-05 Issue:3 Volume:13 Page:233-237
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast Journal

Author:

Chagpar Anees B.,Scoggins Charles R.,Martin Robert C. G.,Sahoo Sunati,Carlson David J.,Laidley Alison L.,El-Eid Souzan E.,McGlothin Terre Q.,McMasters Kelly M.,

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1524-4741.2007.00415.x/fullpdf

Reference24 articles.

1. Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node?

2. Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation

3. Treatment of Early Breast Cancer: A Report after Ten Years of a Clinical Trial

4. The Significance of Local Control in the Primary Treatment of Breast Cancer

5. Revision of the American Joint Committee on Cancer Staging System for Breast Cancer

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgeon Factors Influencing Breast Surgery Outcomes: A Scoping Review to Define the Modern Breast Surgical Oncologist;Annals of Surgical Oncology;2023-04-10

2. Lymphedema After Axillary Lymph Node Dissection in Breast Cancer: Prevalence and Risk Factors—A Single-Center Retrospective Study;Lymphatic Research and Biology;2022-12-01

3. Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer;Frontiers in Oncology;2021-09-30

4. Evaluating the Impact of Immediate Lymphatic Reconstruction for the Surgical Prevention of Lymphedema;Plastic & Reconstructive Surgery;2021-02-23

5. Outcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes;Journal of Cancer;2020